Bassenge E, Fink B
Institut für Angewandte Physiologie, Universität Freiburg, Germany.
Naunyn Schmiedebergs Arch Pharmacol. 1996 Feb;353(3):363-7. doi: 10.1007/BF00168641.
We analysed the induction of tolerance to nitrates both in the vasculature (in vivo) and platelets (ex vivo). Simultaneously, we tested mechanisms underlying the induction of tolerance and interventions to prevent or overcome this phenomenon. For this purpose nitroglycerin (GTN 1.5 micrograms/kg per min i.v.), alone or in combination with ascorbate (55 micrograms/kg per min i.v.) as antioxidant, was infused continuously for a period of 5 days into chronically instrumented dogs. Along with haemodynamic parameters, ex vivo platelet function was continuously monitored. Following the start of GTN infusions there was a maximal coronary dilator response (245 +/- 15 microm) and, as an index of venodilation, a fall of left ventricular end-diastolic pressure (by 2.3 +/- 0.4 mmHg). Both responses declined progressively and disappeared during the infusion period. However, in combination with ascorbate as antioxidant the dilator responses were maintained fully throughout the infusion period. With GTN alone there was a progressive, unexpected upregulation of platelet activity demonstrated by enhanced thrombin-stimulated intracellular Ca2+ levels and increases in the microviscosity of platelet membranes (indicating enhanced receptor expression) associated with a progressive impairment in basal, unstimulated cGMP levels. These changes could also be prevented completely by i.v. co-administration of ascorbate. From these results it is concluded that vascular tolerance is closely reflected by simultaneous changes in platelet function and further, that both can be prevented completely by appropriate antioxidants such as ascorbate.
我们分析了血管系统(体内)和血小板(体外)对硝酸盐耐受性的诱导情况。同时,我们测试了耐受性诱导的潜在机制以及预防或克服这一现象的干预措施。为此,将硝酸甘油(GTN,静脉注射1.5微克/千克每分钟)单独或与抗坏血酸盐(静脉注射55微克/千克每分钟)作为抗氧化剂联合使用,连续5天注入长期植入仪器的犬体内。除血流动力学参数外,还持续监测体外血小板功能。在GTN输注开始后,出现了最大冠状动脉扩张反应(245±15微米),作为静脉扩张指标,左心室舒张末期压力下降(2.3±0.4毫米汞柱)。两种反应在输注期间均逐渐下降并消失。然而,与作为抗氧化剂的抗坏血酸盐联合使用时,扩张反应在整个输注期间完全得以维持。单独使用GTN时,血小板活性出现了渐进性、意外的上调,表现为凝血酶刺激的细胞内钙离子水平升高以及血小板膜微粘度增加(表明受体表达增强),同时基础未刺激的cGMP水平逐渐受损。静脉联合给予抗坏血酸盐也可完全预防这些变化。从这些结果可以得出结论,血管耐受性通过血小板功能的同时变化得到密切反映,而且,两者均可通过适当的抗氧化剂如抗坏血酸盐完全预防。